• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gilead Sciences (NQ: GILD )

    72.70 -0.81 (-1.10%)
    Streaming Delayed Price Updated: 2:42 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Gilead Sciences

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    48 49 Next >
    If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
    Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July. 
    Via InvestorPlace
    Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025
    From Gilead Sciences, Inc.
    Via Business Wire
    Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays
    These three dividend vehicles could provide reliable passive income. 
    Via The Motley Fool
    Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024
    From Gilead Sciences, Inc.
    Via Business Wire
    Gilead Sciences's Options Frenzy: What You Need to Know
    Via Benzinga
    Looking Into Gilead Sciences's Recent Short Interest
    Via Benzinga
    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today
    Via Benzinga
    The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
    Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market. 
    Via InvestorPlace
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather 
    Via MarketBeat
    3 Dividend Growth Stocks to Buy and Hold
    What's better than a dividend? A dividend that's growing. 
    Via The Motley Fool
    Is Iovance Biotherapeutics a Millionaire Maker?
    This biotech's future is bright, but how good could it get for investors? 
    Via The Motley Fool
    The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
    Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector. 
    Via InvestorPlace
    Key Takeaways From Gilead Sciences Analyst Ratings
    Via Benzinga
    Gilead Sciences's Options Frenzy: What You Need to Know
    Via Benzinga
    3 Underappreciated Stocks About to Break Their Chains
    Explore these underappreciated stocks ready for growth and get an in-depth analysis, forecasts, and news on these potential breakout stocks. 
    Via InvestorPlace
    Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today
    On Monday, the Dow Jones (US30) decreased by 0.08%, while the S&P 500 (US500) added 0.10%. The NASDAQ Technology Index (US100) closed positive 0.28%. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    7 Cheap Biotech Stocks With Major Upside Potential
    While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. 
    Via InvestorPlace
    Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
    Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
    Via Talk Markets
    This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
    Via Benzinga
    Amgen, Inc. Dividend Stock Analysis
    Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis. 
    Via Talk Markets
    FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
    Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals. 
    Via InvestorPlace
    Exposures Product Safety
    3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
    These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise. 
    Via InvestorPlace
    3 Magnificent Stocks Retirees Can Buy and Hold Forever
    These stocks could be ideal for investors in their golden years. 
    Via The Motley Fool
    Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    7 Dividend Stocks to Buy Now: June 2024
    These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands. 
    Via InvestorPlace
    DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
    Top performers last week were SRPT (+29.50%), SIRI (+16.73%), TOST (+15.57%), GILD (+12.62%), CHWY (+10.59%), ACN (+9.80%), DKNG (+9.69%), DELL (+8.19%), ADSK (+7.99%), and GFI (+7.15%). 
    Via Benzinga
    MarketBeat Week in Review – 6/17 - 6/21
    Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally 
    Via MarketBeat
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Top Analyst Reports For Abbott, BP & Gilead
    Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and... 
    Via Talk Markets
    Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market
    Stock market rally continues with new highs in S&P 500 and Nasdaq 100, driven by tech and semiconductor sectors, but concerns arise over lack of broad participation and high concentration in mega-cap... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Economy US Equities
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    48 49 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.